UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Price negotiations begin for breast cancer combo drugs
by Kim Yun-mi
2020-03-25 16:25
‘Outbreak will stop when 60% of Koreans become immune to COVID-19’
by Kim Yun-mi
2020-03-24 16:19
Study begins to compare 2 treatments for mild COVID-19 patients
by Kim Yun-mi
2020-03-24 13:35
Drug sales reps turning to digital promotions
by Kim Yun-mi
2020-03-23 16:15
‘No evidence for hypertension drug’s harmful effect on COVID-19 patients’
by Kim Yun-mi
2020-03-18 16:48
라인
HIV combo drug Dovato scores local nod
by Kim Yun-mi
2020-03-17 15:58
Medical group calls for reopening Gaeseong complex to make masks
by Kim Yun-mi
2020-03-12 17:07
COVID-19 robs local cardiologists of chance to present inspiring research
by Kim Yun-mi
2020-03-12 11:25
45 COVID-19 test kits waiting for approval
by Kim Yun-mi
2020-03-11 14:12
AbbVie’s Skyrizi expected to rock local psoriasis treatment market
by Kim Yun-mi
2020-03-11 11:29
라인
Astellas’ Xospata wins license for acute myeloid leukemia
by Kim Yun-mi
2020-03-09 16:40
295 Koreans to get remdesivir to fight COVID-19
by Kim Yun-mi
2020-03-09 11:05
Takeda begins developing COVID-19 plasma therapy TAK-888
by Kim Yun-mi
2020-03-06 14:35
Smart patient monitoring system installed at KUMC’s coronavirus facility
by Kim Yun-mi
2020-03-05 15:46
Korea nods testing remdesivir in COVID-19 patients
by Kim Yun-mi
2020-03-04 13:46
라인
US firm to test potential coronavirus vaccine mRNA-1273
by Kim Yun-mi
2020-03-03 15:29
‘S. Korea should pay attention to North’s coronavirus control’
by Kim Yun-mi
2020-03-02 17:53
US begins to test remdesivir for COVID-19 treatment
by Kim Yun-mi
2020-02-26 15:21
Will Korean COVID-19 patients get to use remdesivir for compassionate use?
by Kim Yun-mi
2020-02-24 17:41
Labor group slams Fresenius for allegedly breaching labor law
by Kim Yun-mi
2020-02-21 16:39
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top